Ona Therapeutics SL

Ona Therapeutics is a biotech company, spin-off of ICREA and IRB, specialized in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. It was co-funded in February 2019 by ICREA researcher Salvador Aznar Benitah and Valerie Vanhooren (CEO). It is currently based at the Parc Cientific de Barcelona (PCB) and IRB Barcelona. ONA Therapeutics has been launched through an investment by Asabys Partners, who is a venture capital firm from Barcelona investing across the board in human healthcare, specialising in health-tech and biopharma industries.